Therapies targeting exogenous cholesterol uptake: new insights and controversies
- PMID: 21188557
- DOI: 10.1007/s11883-010-0151-2
Therapies targeting exogenous cholesterol uptake: new insights and controversies
Abstract
Exogenous cholesterol uptake involves a complex process in the intestines for the absorption of cholesterol and bile acids. This process is regulated by intestinal nuclear transcription factors such as LXR that affect sterol transporters NPC1L1, ABCG5/G8, and ABCG1, and enzymes such as ACAT-2. Plant sterol/stanols, ezetimibe, and bile acid sequestrants have a variety of effects on these various transporters, and new insights into their mechanism(s) of action have provided a plethora of exciting targets for metabolic diseases, dyslipidemia, and atherosclerosis.
Similar articles
-
Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.Atherosclerosis. 2008 May;198(1):77-84. doi: 10.1016/j.atherosclerosis.2007.10.012. Epub 2007 Dec 3. Atherosclerosis. 2008. PMID: 18054357 Free PMC article.
-
Inhibition of cholesterol absorption: targeting the intestine.Pharm Res. 2012 Dec;29(12):3235-50. doi: 10.1007/s11095-012-0858-6. Epub 2012 Aug 25. Pharm Res. 2012. PMID: 22923351 Review.
-
rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.Atherosclerosis. 2013 Jul;229(1):94-101. doi: 10.1016/j.atherosclerosis.2013.04.009. Epub 2013 May 10. Atherosclerosis. 2013. PMID: 23725986
-
Sterol transporters: targets of natural sterols and new lipid lowering drugs.Pharmacol Ther. 2005 Mar;105(3):333-41. doi: 10.1016/j.pharmthera.2004.10.011. Epub 2004 Dec 9. Pharmacol Ther. 2005. PMID: 15737409 Review.
-
Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).Atheroscler Suppl. 2008 Sep;9(2):77-81. doi: 10.1016/j.atherosclerosissup.2008.05.008. Epub 2008 Jun 27. Atheroscler Suppl. 2008. PMID: 18585981 Review.
Cited by
-
Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice.FASEB J. 2013 Sep;27(9):3805-17. doi: 10.1096/fj.12-223008. Epub 2013 Jun 10. FASEB J. 2013. PMID: 23752203 Free PMC article.
-
Non-Coding RNAs as Critical Modulators of Cholesterol Metabolism in Cancer.Biomedicines. 2025 Jul 3;13(7):1631. doi: 10.3390/biomedicines13071631. Biomedicines. 2025. PMID: 40722703 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical